HIV Diagnostics Market Analysis

HIV Diagnostics Market Analysis

HIV diagnostics market based on test type is classified into viral load test, antibody test, and CD4 test. Viral load test segment accounted for more than USD 450 million in 2021. Viral load test is a laboratory test to measure the viral load in patient’s body. These tests enhance treatment quality & better outcomes among infected patients.
 

High usage of viral load test is performed repeatedly to monitor viral load in the patients undergoing ART treatment. Now a days, these tests can be performed outside the laboratory settings by using advanced point-of-care molecular testing. Furthermore, strong product portfolio and presence of key industry players in the segment will drive segmental demand.
 

For instance, in 2019, Roche Diagnostics launched Cobas plasma separation card for viral load testing. This has strengthened company’s HIV diagnostics product portfolio. Thus, several developments in the segment will boost the adoption of viral load tests.
 

HIV diagnostics market based on end-use is classified into diagnostics laboratories, hospitals & clinics, home settings, and others. Diagnostic laboratories segment dominated the market and is estimated to witness 0.8% CAGR during forecast period. Continuous technological advancements in laboratory devices to enhance the testing outcomes will bolster segment growth. Growing awareness in patients regarding HIV diagnostics in urban & rural areas will fuel the segmental growth. High patient preference towards diagnostic laboratories owing to accurate diagnosis and patient care will foster the segmental expansion in forthcoming years.
 

Africa HIV diagnostics industry captured nearly 38% market share in 2021 and is poised to grow enormously over analysis timeframe. High prevalence rate of HIV infections in the African countries due to high rate of sex works, increasing rate of teenage pregnancy, lack of quality sex education are some major factors contributed to regional market growth.
 

Also, rising awareness initiatives by government and private players regarding HIV diagnostics and testing procedures, and growing presence of several industry players in this region will positively influence the overall market expansion. Moreover, growing adoption of point of care testing in several countries will further drive the adoption of HIV diagnostics tests in African countries.